NASDAQ · NEGGHealthcareSurgical Instruments

Newegg Commerce financials

$13.20−0.23%
Close Sep 30, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
FY24
Dec 31
FY23
Dec 31
FY22
Dec 31
FY21
Dec 31
Revenue$1.44B$1.24B$1.50B$1.72B$2.38B
Gross profit$168.5M$131.5M$167.6M$216.6M$326.0M
Gross margin11.7%10.6%11.2%12.6%13.7%
Operating income-$9.5M-$51.6M-$71.1M-$49.5M$33.5M
Net income-$4.9M-$43.3M-$59.0M-$57.4M$36.3M
Net margin−0.3%−3.5%−3.9%−3.3%1.5%
Diluted EPS$-0.24$-2.25$-3.12$-3.08$1.60
EBITDA-$2.0M-$40.8M-$57.6M-$38.5M$44.4M
Operating cash flow-$27.0M-$821.0K-$3.8M$20.5M-$53.3M
Free cash flow-$29.7M-$4.4M-$34.1M$11.3M-$67.1M
Diluted shares20.1M19.3M18.9M18.7M21.6M

Balance sheet

Period endDec 31Dec 31Dec 31Dec 31Dec 31
Cash & equivalents$107.8M$96.3M$102.5M$122.6M$100.0M
Short-term investments$0.00$0.00$0.00$0.00—
Total debt$6.3M$7.1M$8.7M$7.7M$8.3M
Total assets$468.9M$407.3M$499.0M$542.1M$626.6M
Total liabilities$308.2M$301.2M$369.7M$386.9M$444.3M
Shareholders' equity$160.7M$106.1M$129.4M$155.2M$182.3M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology